Xcel Energy's fourth-quarter net income rose sharply, and the Midwestern utility reiterated its projection for 2026 adjusted earnings growth as it continues to benefit from the surge in power demand ...

With the stock's last traded price at Rs 2,553.50, Endurance Technologies experienced a decline of 2.06% amid high volume trading.

Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news like ...

Nvidia has invested $2 billion in AI infrastructure provider CoreWeave, the companies announced. Shares of CoreWeave popped on the news. Nvidia purchased CoreWeave Class A common stock at $87.20 per ...

Abbott Laboratories reported Q4 2025 sales of $11.46 billion, an increase of 4.4% from the previous year but falling short of analyst projections by approximately 3%. The adjusted EPS was $1.50, ...

Shares in Intel Corporation (Nasdaq: INTC) are plunging in premarket trading this morning. The stock price fall comes after the chipmaker reported its Q4 2025 earnings after the closing bell yesterday ...

This video's transcript was generated by a third party. It is not curated or reviewed and is provided for convenience and information purposes only. The accuracy and completeness of the transcript are ...

A familiar Wall Street voice just changed the tone. Goldman Sachs rates Microsoft a buy, assigning a jaw-dropping price target and citing AI potential. Microsoft’s Copilot and AI agents drive user ...

U.S. officials will meet with Greenland and Denmark’s foreign ministers today Dow Jones Industrial Average (DJIA), Nasdaq-100 Index (NDX), and S&P 500 Index (SPX) futures are pointed lower this ...

Earnings announcements are one of the few scheduled events that consistently move markets. Prices react not just to the reported numbers, but to how those numbers compare with expectations. A small ...

A pair of phase 3 psoriasis studies of Alumis’ TYK2 inhibitor have hit their primary endpoints, setting the biotech up to file for approval of a potential challenger to Bristol Myers Squibb’s Sotyktu.

The stock of the AI data center company, Hyperscale Data, Inc. (NYSE American: GPUS), surged 50% on Jan. 2 after traders got hold of the news of a massive share purchase by the company's director.